Eli Lilly has announced positive top-line results from the Phase III BRUIN CLL-314 trial of Jaypirca (pirtobrutinib), a ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

Sweden’s Enzymatica has appointed Sana Alajmovic as its new chief executive (CEO), succeeding Claus Egstrand, who has ...

The US Food and Drug Administration (FDA) has announced the fiscal year 2024 Report on the State of Pharmaceutical Quality ...

Castleman’s disease (CD) refers to a group of rare lymphoproliferative disorders characterized by abnormal lymph node ...

Shanghai Fosun Pharma has signed a license agreement with Expedition Therapeutics, granting the latter rights to develop, manufacture, and commercialize XH-S004, an orally administered dipeptidyl ...

US clinical-stage biotech Vor Bio has announced the appointment of Dallan Murray as chief commercial officer, effective ...

Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with ...

Denmark-based IO Biotech’s shares traded 51% higher ahead of the morning bell at $2.74 after the company said that Cylembio ...

Chinese drugmaker Kexing Biopharm (SHA: 688136) has entered a strategic partnership with US life sciences services group ...

French manufacturer Sartorius Stedim Biotech and Nanotein Technologies, a developer of next-generation immune cell activation ...

Vinay Prasad has returned to lead the US regulator’s Center for Biologics Evaluation and Research, resuming responsibility ...